University of Oklahoma Celebrates Grand Opening of its 4,000-sq-ft Bioprocessing Core Facility
The University of Oklahoma (OU) celebrated the grand opening of its 4,000-sq-ft bioprocessing core facility (BCF) with a ribbon-cutting ceremony. This multimillion-dollar facility is a key piece in the state’s drive to become a...
Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe
Daniel Burch, MD, is a senior vice president leading global biotech solutions for Thermo Fisher’s clinical research and pharma services businesses.
Thermo Fisher Scientific’s Accelerator Drug Development solutions, which integrate services for contract development and...
Beetle-inspired tuberculosis testing device offers accurate detection for people with HIV
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm.While...
Global effort enters an active growth phase to preserve the Earth’s microbial heritage
A global effort to create a "microbial Noah's Ark" to preserve the world's diverse collection of healthy microbes before they disappear is now entering an active growth phase. In a perspective article published in...
Vetter Begins Construction of Clinical Manufacturing Site in Illinois
German CDMO Vetter held an official groundbreaking ceremony for the start of construction on a clinical manufacturing site in Des Plaines, IL. The company has invested approximately $285 million in the new facility.
Upstream and...
Accelerating In Vivo CAR-T Development Using Single Nanoparticle Characterization
Panelists:
Joseph Brealey ResearcherNanoFCM View Bio
Panelist ...
Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412
Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical trial (NCT06414460) to evaluate ISM3412, a potentially best-in-class,...
Managing Cancer Patients’ Microbiota: An Ecological Approach
In recent years, the relationship between the human microbiota and cancer treatment outcomes has emerged as one of the most compelling frontiers in medical research. These intricate microbial ecosystems dwelling within our intestines exert...
LMU researchers uncover mechanism for metabolism without cell membranes
LMU researchers have demonstrated a possible mechanism for metabolic processes without cell membranes in water-filled pores. Looking at life today, it is difficult to imagine how complex biological processes and structures could have developed...
Deciphering the structure of human protease SENP5 unlocks new therapeutic paths
A research led by the IBB-UAB has managed to decypher the structure of the human protease SENP5, implicated in neurodegenerative disorders, cardiovascular diseases and the development of cancer. The research, published in Nature Communications,...
